RK-251: What we know about India’s new ‘smart’ cancer drug that ‘could replace chemotherapy’
Researchers in India developed RK-251, a new experimental cancer drug that activates only inside cancer cells, potentially replacing traditional chemotherapy. In preclinical studies, it demonstrated strong efficacy against aggressive triple-negative breast cancer while sparing healthy cells. Further research is needed before human trials can commence, as the drug shows promise for safer cancer treatment.